Delivery Order SPE2DB22D1017-SPE2DB25FE8RQ
Award Date
11/6/24
Potential Completion Date
11/7/24
Potential Value
$6.1K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of FLUTICASONE-SALMETEROL 230-21 12GM, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price, valued at $24,109.79, and has an ultimate completion date of March 17, 2025. The contract does not have a set-aside designation, indicating open competition....
This federal contract award is for the delivery of FLUTICASONE-SALMETEROL 115-21 12GM pharmaceutical products to the Defense Logistics Agency (DLA) Troop Support Medical. The $3,423.32 firm-fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on October 29, 2024 with an ultimate completion date of October 30, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award, valued at $1,841.35, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of FLUTICASONE-SALMETEROL 45-21 12GM, a pharmaceutical product, with a completion date of February 24, 2025. The contract is structured as a Delivery Order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical,...
This federal contract award is for the delivery of FLUTICASONE-SALMETEROL 45-21 12GM pharmaceutical products to the Defense Logistics Agency (DLA). The $5,786.50 Firm Fixed Price contract was awarded to Amerisourcebergen Drug Corporation, a major pharmaceutical distributor, on April 22, 2024. The contract has an ultimate completion date of April 23, 2024 and is not set aside for any specific business type. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) valued up to...
This federal contract award is for the delivery of the pharmaceutical product "FLUTICASONE-SALMETEROL 230-21 12GM" to the Defense Logistics Agency (DLA). The contract was awarded to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for a ceiling value of $3,887.90. The contract is a Delivery Order with a Firm Fixed Price pricing type and an ultimate completion date of December 16, 2024. There is no set-aside...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,201.98, is for the delivery of FLUTICASONE-SALMETEROL 230-21 12GM, a pharmaceutical product. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of April 10, 2025. The contract does not have a set-aside designation, indicating open competition....
This federal contract award is for the delivery of Fluticasone-Salmeterol 230-21 12GM pharmaceutical products to the Defense Logistics Agency (DLA). The contract, valued at $8,346.72, was awarded to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price pricing type, and has an ultimate completion date of October 17, 2024. The contract was not designated with a set-aside...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,963.95, is for the delivery of FLUTICASONE-SALMETEROL 230-21 12GM, a pharmaceutical product. The contract is a Delivery Order with a Firm Fixed Price pricing type, and the ultimate completion date is April 2, 2025. The contract award is not associated with a set-aside designation, indicating...
This federal contract award is for the delivery of fluticasone-salmeterol 230-21 12GM, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $2,981.33 firm fixed-price contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on December 9, 2024, with a completion date of December 10, 2024. The contract is a delivery order without any set-aside designation, indicating open competition. Amerisourcebergen Drug Corp maintains a $999,999,999 Indefinite...
The federal contract award is for the delivery of fluticasone-salmeterol 115-21 12GM pharmaceutical products to the Defense Logistics Agency (DLA), a defense agency, with a ceiling value of $1,551.02. The contract is a firm fixed-price delivery order, with an ultimate completion date of June 10, 2025. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider headquartered in Conshohocken, Pennsylvania. This contract is not set-aside...